?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Katie Quinn
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 12, 2018
Katie Quinn
Biosimilars Forum Commends FDA Commissioner For Raising Awareness Of Biosimilars
News
July 9, 2018
Katie Quinn
Biosimilars Forum Convenes Stakeholder Groups to Discuss Advancing Biosimilars
News
June 27, 2018
Katie Quinn
Biosimilars Forum Releases Position on Non-Medical Switching
News
June 21, 2018
Katie Quinn
Biosimilars Forum Applauds FDA Decision to Reevaluate Draft Guidance
News
May 16, 2018
Katie Quinn
Biosimilars Forum Applauds Approval of 10th Biosimilar in United States
News
May 11, 2018
Katie Quinn
Biosimilars Forum Encouraged by Trump Administration’s Support for Biosimilars
News
March 9, 2018
Katie Quinn
Biosimilars Forum Encouraged By Food And Drug Administration Commissioner’s Support of Biosimilars
News
February 22, 2018
Katie Quinn
Biosimilars Forum Opposes Efforts to Prohibit Biosimilars From Receiving Pass-Through Payment Status
News
February 12, 2018
Katie Quinn
Biosimilars Forum Supports Inclusion of Biosimilars in the Medicare Coverage Gap Discount Program
News
November 2, 2017
Katie Quinn
Biosimilars Forum Applauds CMS Decision to Reverse Existing Rule on Biosimilar Reimbursement Policy
Prev page
02
03
04
05
06
Next page